Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine

INSTRUCTIONS FOR COMPLETING THE DEA FORM 488:
Application for Import Quota for Ephedrine, Pseudoephedrine, and
Phenylpropanolamine

The DEA-488 must be filed on or before April 1 of the year preceding the calendar year
for which the import quota is being applied. Regulations governing quotas are included
in Title 21, Code of Federal Regulations, Part 1315. Copies of these regulations may be
ordered from: The Government Printing Office, Superintendent of Documents, Attn: New
Orders, P.O. Box 371954, Pittsburgh, PA 15250-7954. Submit the completed form to:
Drug Enforcement Administration
Office of Diversion Control (ODE)
8701 Morrissette Drive
Springfield, VA 22152

The following instructions are for those items which are not completely self-explanatory:
Item 11. Under the “current year” heading, write the year in which the application is
being submitted, and write the 1st and 2nd preceding year to the “current year” under the
corresponding headings. Under the “quota requested” heading write the year for which
the quota is being requested, the year entered in item 4.
Item 12(I). For each of the corresponding years enter the known or estimated inventory
in grams of anhydrous acid, base, or alkaloid as of December 31 of that year. The
inventory should be separated into the following subcategories: bulk material, in-process
material, and contained in finished dosage forms.
Item 12(II). Worksheet A should only be completed for domestic sales and/or utilization
for the year for which the import quota is being requested. For the domestic and export
disposition (sales)/utilization, subcategories (a) and (b), respectively, the information
should be entered for the 1st and 2nd preceding years, current year and year quota
requested categories.
Item 13. Enter any new substances, controlled substances or List I chemicals, which
would be manufactured from the List I chemical for which the quota application is being
submitted. Also include the yield of the reaction or synthesis of the new substance.
Item 14. List each dosage form in which the requested List I chemical will be
manufactured, packaged, or labeled. Include the strengths of the manufactured dosage
forms. Enter the amount of the List I chemical used or estimated to be used for the
manufacture of each dosage form for each year. Provide the authority by which you may
legally market the product under the Federal, Food, Drug & Cosmetic Act.

Privacy Act Information
Authority: Section 1002 of the Controlled Substances Import and Export Act
Purpose: Control importation of ephedrine, pseudoephedrine, phenylpropanolamine,
into the United States.
Routine Uses: The Import/Export Declaration produces information required for law
enforcement purposes. Disclosures of information from this system are
made to the following categories of users for the purposes stated.
A. Other Federal law enforcement and regulatory agencies for law
enforcement and regulatory purposes.
B. State and local law enforcement and regulatory agencies for law
enforcement and regulatory purposes.
C. Persons registered under the Controlled Substances Act (P.L. 91-513)
for the purpose of verifying the registration of customers
Effect: Failure to complete this form will preclude the import of the chemicals
mentioned.
Under the Paperwork Reduction Act, a person is not required to respond to a collection of
information unless it displays a current valid OMB control number. Public reporting
burden for this collection of information is estimated to average 1 hour, including the
time for reviewing instructions, searching existing data sources, gathering and
maintaining the data needed, and completing and reviewing the collection of information.
Send comments regarding this burden estimate or any other aspect of this collection of
information, including suggestions for reducing this burden, to the FOI and Records
Management Section, Drug Enforcement Administration, Washington, D.C. 20537; and
the Office of Management and Budget, Paperwork Reduction Project No. 1117-0047,
Washington, D.C.